, is a central event leading to neurodegeneration in prion diseases. Deciphering the molecular and cellular changes imparted by PrP Sc accumulation remains an arduous task, due to the small number of cell lines supporting prion replication. Here, we introduce the 1C11 cell line as a new in vitro model to investigate prion pathogenesis. This cell line is a committed neuroectodermal progenitor able to differentiate into fully-functional serotonergic or catecholaminergic neurons. 1C11 cells, which naturally express PrP C from the undifferentiated state, can be chronically infected with various prion strains. Prion infection does not promote any noticeable phenotypic change in the progenitor cells nor prevents the onset of the serotonergic and catecholaminergic differentiation programs. Pathogenic prions however deviate the overall neurotransmitter-metabolism in both pathways, by decreasing bioamine synthesis, storage and transport, and enhancing catabolism. Noteworthy, oxidized derivatives of both serotonin and catecholamines are selectively detected in the differentiated progenies of infected cells and contribute to irreversible impairment in bioamine synthesis. Finally, the level of PrP Sc accumulation, that of infectivity and the extent of all prion-induced changes in infected cells appear to be correlated. The report of such specific effects of infection on neuronal functions provides a foundation for dissecting the events underlying loss of neuronal homeostasis in prion diseases.
Prion diseases or transmissible spongiform encephalopathies (TSEs) are a group of fatal neurodegenerative disorders that includes scrapie and bovine spongiform encephalopathy (BSE) in animals, and Creutzfeldt-Jakob disease (CJD) in humans (1) . While sharing some hallmarks with other neurodegenerative diseases such as Alzheimer's or Parkinson's disease, TSEs are unique in that they can have a genetic, sporadic or infectious origin. An enigmatic feature of infectious TSEs is the high latency that may range between a few months up to several decades. The occurrence of various prion strains associated with different incubation periods, clinical manifestations and neuropathological lesions, further illustrates the complexity of the host-pathogen relationship in the TSE field.
A key event in TSE pathogenesis is the conversion of the cellular isoform of the prion protein, PrP C , into an abnormal conformational variant called PrP Sc , which stands for the scrapie isoform of the prion protein (1) . The central role played by PrP C in the development of prion diseases was first exemplified by the observation that PrP knock-out mice are resistant to TSE, while PrP-overexpressing (tga20) mice exhibit reduced incubation periods as compared to wildtype mice (2) . Neurograft experiments carried out on PrP-/-mice using tga20 mice as brain tissue donors allowed to clearly demonstrate that the presence of endogenous PrP C is mandatory for PrP Sc to induce pathological alterations (3). Mallucci et al (4) further showed that switching off PrP C neuronal expression in infected mice, just prior to the clinical phase, blocks TSE pathogenesis, although abundant prion replication still occurs in extraneuronal tissues. These experiments thus outline that prions require neuronal PrP C to exert their toxicity. This notion was recently reasserted and refined in a study based on transgenic mice expressing a GPI anchor-less PrP C (Δ GPI PrP) (5). Indeed, ΔGPI PrP infected mice were found to efficiently replicate scrapie and accumulate high levels of PrP Sc in their brains without any sign of clinical illness. As a whole, these data argue for a primary role of neuronal, GPI-anchored PrP C in prion neuropathogenesis.
Despite this overall advance, unraveling the sequence of cellular and molecular events that lead to neuronal cell demise in TSEs still constitutes an ongoing challenge. Exploiting cell culture systems that sustain stable prion replication represents a valuable approach to tackle this issue. Over the past decade, prioninfected cell lines of neural or non-neural origin have shed much light on PrP Sc biogenesis, conversion, and trafficking (6) . In addition, their use as tools to detect infectivity (7), screen therapeutic compounds (8) or evaluate immunotherapy-based strategies ((9) and references therein) has been widely acknowledged. However, they have provided but little insight into PrP Sc -induced cellular dysfunction, since, in most cases, prion infection had no obvious impact on the cell phenotype. Prion replication was nevertheless found to alter cholinergic functions in PC12 pheochromocytoma cells (10) . In GT1 hypothalamic cells, infection is associated with reduced viability (11) and increased susceptibility to oxidative stress (12) . Increased rates of apoptosis were also recently observed upon infection of primary neuronal cultures derived from tg338 mice overexpressing ovine PrP (13) .
Investigating how prions disrupt neuronal cell function may be notably hindered by the relative scarcity of cell systems of neural origin supporting prion replication to date. Here, we introduce the 1C11 neuroectodermal clone, which naturally expresses PrP C (14) , as a novel prionpermissive cell line. The murine 1C11 progenitor derives from F9 pluripotent embryonal carcinoma cells and behaves as a committed neuronal stem cell (15) . This cell line has the unique capacity to differentiate, upon induction, into fully functional serotonergic (1C11 5-HT ) or noradrenergic (1C11 NE ) cells. In the presence of dibutyryl cyclic AMP (Bt2cAMP), the 1C11 progenitor adopts a neuronal morphology and starts expressing neuron-associated markers. Within 4 days, almost 100% of the precursor cells convert into 1C11 cells that display a complete serotonergic phenotype including serotonin (5-HT) synthesis, storage, catabolism and transport (15) . On another hand, 12 days after the addition of Bt2cAMP in combination with dimethylsulfoxide (DMSO), 1C11 NE cells implement a complete noradrenergic differentiation program (15) .
In the present work, we demonstrate that 1C11 cells support the replication of various prion strains. Our results show that PrP Sc accumulation does not prevent the entry of 1C11 cells into either neuronal differentiation program, but, however, triggers specific alterations of the overall neurotransmitter-associated functions in both 1C11
5-HT and 1C11 NE cells. In addition, prions promote the production of oxidized derivatives of either serotonin or catecholamines, which are critically involved in bioaminergic dysfunctions. Finally, the extent of all prioninduced changes in infected cells correlate with the level of PrP Sc accumulation and that of infectivity.
incubated for 4 to 5 hrs with 1 ml of brain homogenate diluted at 0.2% in serum-free DMEM. 1 ml of FCS-supplemented medium was then added. Cells were passaged at a 1:10 dilution every 3 or 4 days, and PrP Sc was assayed by immunoblotting after 5 and 10 passages. Subcloning was performed at the first passage following the infection by limiting dilution (0.3 cell per 6 mm titer well). The clones were then expanded and the production of PrP Sc was tested by immunoblotting.
I m m u n o b l o t t i n g -Protein extraction and immunological detection of PrP
Sc by Western blotting in mouse brain homogenates or cell lysates were conducted using SAF mix as described previously (16) . Briefly, 0.5 mg of total protein was digested with 10 µg of proteinase-K at 37 °C for 30 min, supplemented with 1mM Pefabloc and centrifuged at 20 000g for 45 min. The pellet was resuspended in 1 × Laemmli sample buffer and boiled for 5 min before SDS-10 % PAGE and electrotransfer on nitrocellulose membrane (Amersham Pharmacia, Arlington Heights, IL, USA). PrP was detected using a mixture consisting of an equal volume of ascites of SAF 60, 69 and 70 antibodies (CEA, Saclay, France), namely SAF mix. Western blots were revealed with an enhanced chemiluminescence detection system (ECL, Amersham Pharmacia). Bioassay-Tga20 mice over-expressing wild-type Mo Prnp-a (kindly provided by Dr. Charles Weissmann) were inoculated intracerebrally with 20 µl of sample containing 0.1% or 10% of Fukuoka-1 brain homogenate or cell extracts (2.10 6 cells). Cells were submitted to three freezethaw cycles and suspensions were sonicated for 2 min (Cup-horn sonicator). Each sample was inoculated to 6 mice. Mice were monitored every 2 days, and the time at which they presented mouse-scrapie symptoms and terminal point were recorded as described previously (17) . Quantification of enzymatic activitiesDetermination of enzymatic functions was conducted on uninfected and infected cells after induction of serotonergic or catecholaminergic differentiation. Cells were plated onto 10-cm culture dishes and differentiated into serotonergic neurons for 2 or 4 days or into catecholaminergic neurons for 8 days. After two washings with cold PBS, cells were scraped and collected down by centrifugation (10000×g, 3 min, 4 °C). Enzymatic activities for neurotransmitter synthesis were measured radioenzymatically as in (18 (21) . Briefly, cells were harvested in PBS containing a cocktail of inhibitors (Roche). Cells were then pelleted by centrifugation and resuspended in cold buffer A containing 4 mM EDTA, 1 mM EGTA, 0.1 mM PMSF 10 mM imidazole, pH 7.3. The supernatant was poured onto a 20% sucrose cushion and centrifuged at 100,000 g for 90 min. The pellet containing crude membranes was resuspended in buffer B (75 mM KCl, 5 mM MgCl 2 , 1 mM EGTA, 10 mM imidazole, pH 7.3). Radioligand binding was performed on crude membranes (20 µg of proteins) in 50 mMTris, pH 7,4 at 37°C. A 30 min incubation period was followed by addition of icecold Tris HCl pH7.4 (5 ml, 10 mM). Samples were filtered on PEI-treated filters and radioactivity retained on filters was counted in liquid and solid scintillation counters (Packard, Issy-les-Moulineaux, France).
Treatment of TPH with infected cell supernatant-TPH was purified from 1C11
5-HT day 4 cells by affinity chromatography using agarose beads coated with antibodies against TPH2 (EC 1.14.16.4). TPH immobilized on agarose beads (about 3µg) was incubated with 1ml of 1C11Fk6 5-HT day 4 supernatants for 15 min at 30°C. Protective agents (GSH, 50 µM, DTT, 500 µM, cysteine, 1 mM, DMSO, 20 mM, SOD 100 U/ml, catalase, 100 U/ml) when present, were added to TPH 10 min before incubation with infected cell supernatant. Beads were washed three times with 50mM potassium phosphate buffer (pH 7.40) and TPH activity was assayed in duplicates. DTNB titration of SH was carried out by the method of Ellman as modified by Riddles et al (22) . Briefly, TPH from 1C11 5-HT day 4 cells, exposed or not to 1C11Fk6 5-HT day 4 supernatants, was incubated with 50 µM DTNB in 50 mM TrisHCl pH 7.50, 6 M guanidine HCl. Absorbance was then recorded at 412 nm using a Cary 100 spectrophotometer (Varian Inc.).
Statistical analysis-Statistics were performed on raw data using Student's t test. The chosen significant criterion was p < 0.01.
RESULTS
The 1C11 neuroectodermal cell line supports prion replication. As an attempt to infect the 1C11 cell line, precursor cells were incubated with brain homogenates (0.2%) from mice inoculated with five distinct mouse-adapted agents derived from scrapie: Chandler, 22L, 22A and ME7, or a human TSE: Fukuoka-1 (23) . After 4 to 5 hr incubation in serum-free medium, the inoculated cells were washed and passaged 5 times (3 weeks). Proteinase K-resistant PrP in the cell lysates was assayed by Western blot. Successful infections of 1C11 cells were obtained for the Chandler, 22L and Fukuoka-1 infected cultures, but not for the ME7 and 22A strains (Fig. 1A) . In all infected cultures, PrP Sc remained detectable after 10 passages (not shown). Notably, PrP Sc signals obtained in the Chandler and 22L infected cells were lower than those observed in Fukuoka-1 infected cells. The later cells were selected for further studies and cloned by limitingdilution, in order to generate cultures with higher and stable PrP Sc production (24) . Two stably infected 1C11Fk clones producing elevated (#6) or moderate (#7) PrP Sc levels (Fig. 1B) were chosen for further investigation. At this stage, no obvious phenotypic differences (growth rate, viability) could be noted between the infected clones and the original 1C11 neuroectodermal cells, when cultured in their undifferentiated conditions. PrP Sc from 1C11Fk clones is infectious. An essential issue was then to assess whether the infected cells also produced infectivity. Pellets of uninfected 1C11 and infected 1C11Fk #6 and #7 cells, passaged 7 times after subcloning, were inoculated intracerebrally to tga20 mice. Mice (n=6) inoculated with 2×10 6 control 1C11 cells remained healthy over more than 250 days post inoculation. In contrast, mice inoculated with 1C11Fk #6 and #7 cells died within a mean incubation time of 76±3.5 (5/5 mice affected) and 89±1.3 (6/6) days, respectively (Fig. 1C) . As a comparison, the latencies of disease in tga20 mice upon inoculation with 20µ l of the original Fukuoka-1 homogenate diluted to 10% or 0.1% were 76± 0.7 (6/6) and 105± 2.4 (5/5) days, respectively. Thus, we conclude that 10 6 1C11Fk #6 cells carry approximately the same level of infectivity as 1 mg of crude Fukuoka-1 infected brain. Noteworthy, there was a 13-day delay between the incubation times with clones #6 and #7. It suggests that the #7 clone contains a tenfold lower level of infectivity than the #6 clone, in agreement with the difference in the PrP Sc contents of the two clones as estimated by Western blot (Fig. 1B) .
Altogether the above data show that 1C11Fk cells are chronically infected and produce infectious prions.
Prion infection impairs serotonin synthesis in 1C11Fk cells. Upon addition of Bt2cAMP, 1C11 cells undergo serotonergic differentiation with a nearly 100% frequency (15) . The acquisition of serotonin-associated functions in differentiating 1C11
5-HT cells is highly synchronous and follows a defined time-schedule (15) . Along the serotonergic pathway, 5-HT synthesis becomes detectable in 1C11 5-HT day 2 cells and reaches maximal levels in 1C11
5-HT day 4 cells (15) .
When exposed to inducers of the serotonergic pathway, 1C11Fk-derived cells, now referred to as 1C11Fk 5-HT , kept producing PrP Sc (Fig. 1D) . To evaluate the ability of prion-infected 1C11Fk cells to implement a serotonergic phenotype, we measured the activity of tryptophan hydroxylase (TPH), the rate-limiting enzyme for 5-HT synthesis, and the 5-HT intracellular content after the addition of Bt2cAMP. As shown in Fig. 2 (A and B) , serotonin synthesis was detected in 1C11Fk
5-HT cells at day 2. However, in 1C11Fk7 and 1C11Fk6-derived progenies, TPH activity reached only 79% and 48%, respectively, of the reference 1C11 5-HT day 2 level (Fig. 2A) . In parallel, a significant decrease (63% of control) in 5-HT content was recorded in 1C11Fk6 5-HT infected cells as compared to uninfected cells (Fig. 2B) . With 1C11Fk7
5-HT cells, the 5-HT content was only slightly reduced (95% of control). The impact of prion infection on 5-HT synthesis was even more pronounced at day 4. While TPH activity and 5-HT content normally increase between day 2 and day 4 of 1C11 serotonergic differentiation ( (15) and Fig. 2 A and B 5-HT cells) argues against the possibility that a small proportion of cells within the culture carry the overall infectivity and account for 5-HT synthesis impairment. We may instead conclude to a dosedependent inhibitory effect of prion infection on serotonin synthesis. In contrast to the above findings, prion infection had no impact on the activity of unrelated enzymes such as glucose-6-phosphate dehydrogenase (G6PDH), the rate limiting enzyme in the pentose phosphate pathway, throughout serotonergic differentiation (Supplementary Fig. 1 ). Hence, 1C11Fk (Fig. 2C) . Again, the raise in 5-HIAA was less pronounced in 1C11Fk7 than in 1C11Fk6 5-HT cells (4.5 fold). According to (25) and our unpublished observations, such an increase in 5-HIAA production may be accounted for by an exacerbated activation of the 5-HT degrading enzyme monoamine oxidase-A (MAO-A). It may also relate to a deficiency in 5-HT storage in infected cells. This is indeed substantiated by the reduced abundance of the vesicular monoamine transporter (VMAT) in infected cells, as assessed by [ 3 H]-tetrabenazine binding experiments (Bmax in 1C11Fk6 5-HT cells = 36% of control) (Fig. 2D) .
The serotonergic program of 1C11 (26, 27) , we wondered whether prion infection would trigger the generation of oxidized bioamine derivatives in 1C11Fk-differentiated progenies. 1C11Fk 5-HT cell culture supernatants were analyzed through HPLC coupled to electrochemical detection. Fractions in phase with redox potential deviation selectively obtained with infected supernatants were collected, dried and analyzed by fast atom bombardment mass spectrometry (FAB-MS) and NMR. Chromatographic peaks 1, 7 and 10 were identified as tryptamine 4,5 dione (T-4,5-D), the dimer 7, 7'-Bi-(5-hydroxytryptamine-4-one) (7,7'-D) and 5,6 dihydroxytryptamine (5,6-DHT), respectively (Fig. 3) . As shown in Fig. 2F , the global concentration of these 5-HT oxidation products was higher in 1C11Fk6 5-HT than in 1C11Fk7
5 -H T supernatants. None of these compounds was detected in 1C11 5-HT control cells (Fig. 2F) . Of note, all three compounds identified in 1C11Fk
5-HT supernatants are detected in central s e r o t o n e r g i c n e u r o n s e x p o s e d t o methamphetamine, where they are endogenously produced as a consequence of serotonin oxidation (28). 5,6-DHT and T-4,5-D mediate the neurotoxicity of methamphetamine towards serotonergic neurons and are classified as serotonin neurotoxins (29) . The production of these oxidized species in 1C11Fk
5-HT cells, within the nanomolar range, did not however impact on cell viability, according to trypan blue exclusion assay (data not shown).
Because T-4,5-D has been reported to irreversibly inactivate TPH through covalent modification of cysteine residues (30), we evaluated the ability of 1C11Fk6 5-HT supernatants to interfere with TPH activity. In these experiments, 1C11
5-HT control cells were used as the source of TPH (see Materials and Methods). Upon incubation with 1C11Fk6 5-HT supernatant, the activity of 1C11 5-HT -derived TPH was reduced by 87% (Fig. 4A) . To get further insight into the mechanisms sustaining the inhibition of TPH activity, 1C11
5-HT -derived TPH was incubated with various protective agents prior exposure to 1C11Fk6 5-HT supernatants. As shown in Fig. 4A , TPH activity was not protected by DMSO, SOD or catalase, which scavenge hydroxyl radicals, superoxide and hydrogen peroxide, respectively. Thus, we may rule out that loss of TPH activity upon exposure to 1C11Fk6 5-HT supernatants is directly caused by ROS. In contrast, GSH or DTT partially rescued TPH activity from inhibition by 1C11Fk6 5-HT supernatants and cysteine fully protected TPH from inactivation (Fig. 4A) . Thus, we conclude that prion-infected cells produce reactive compounds distinct from ROS, which alter TPH activity through selective attack on SH groups. Upon incubation with 1C11Fk6 supernatants, all 12 cysteine residues of TPH were in fact modified, as determined by titration of free SH groups with DTNB (Fig. 4B) . As a whole, these results point to serotonin oxidation products as critical mediators of the damaging effects of prions on neurotransmitter-associated functions.
1C11Fk NE cells display an aberrant noradrenergic metabolism and produce oxidized derivatives of catecholamines. Having shown drastic alterations in neurotransmitter homeostasis upon prion infection along the serotonergic differentiation pathway, we wondered whether the noradrenergic progenies of 1C11Fk cells, referred to as 1C11Fk NE cells, would also be affected by the presence of PrP Sc (see Fig. 1D ). We first compared the activity of tyrosine hydroxylase (TH), the rate-limiting enzyme for NE synthesis, in 1C11Fk6 NE cells and in 1C11 NE control cells. As depicted in Fig. 5A , TH activity was reduced by 95% in the infected cells. In addition, 1C11Fk6 NE cells exhibited dramatic reductions in the levels of L-DOPA (13% of control), dopamine (DA) (4% of control) and NE (3% of control) (Fig. 5B ). This reduction in catecholamine (CA) content was accompanied by an increase (270% of control) in the level of the NE metabolite 3-methoxy-4-hydroxyphenylglycol (MHPG) (Fig.  5C ). At last, in 1C11Fk6 NE cells, the binding capacities of the vesicular transporter (VMAT) were below detectable levels, indicating defects in CA storage (Fig. 5D ). 1C11Fk6 NE supernatants contained various catecholamine oxidation products, such as 6-hydroxydopamine (6-OHDA) and tetrahydroisoquinolines (e.g. salsolinol) (Fig.  5C and data not shown) . The noradrenergic progenies of the #7 clone also exhibited altered CA-associated functions. However, in 1C11Fk7 NE cells, the impact of prion infection was less drastic than in 1C11Fk6 NE cells (Fig. 5) . Thus we may conclude to the dose-dependent effect of PrP Sc on CA metabolism, similarly to the changes evidenced along the serotonergic differentiation pathway.
The above results emphasize that, although infected cells have kept the ability to express all biochemical hallmarks of serotonergic or catecholaminergic differentiation, the presence of PrP Sc deviates the overall neurotransmitter metabolism specific to each pathway. In both cases, bioamine synthesis and storage are decreased and catabolism is enhanced. They point to bioamine-derived oxidized species as a selective consequence of prion accumulation in serotonergic or noradrenergic neuronal cells and a proximal cause of neurotransmitter dysfunction.
DISCUSSION
The present work introduces the 1C11 progenitor, which naturally expresses PrP C , as a novel prion-susceptible cell line. The 1C11 clone efficiently replicates Chandler, 22L and Fukuoka-1 prions. The two clones selected here from a Fukuoka-1 infected culture not only generate PrP Sc but also produce infectivity, as demonstrated by animal assay (Fig. 1C) . The incubation time of the disease in inoculated mice was inversely related to the level of PrP Sc in the infected Fk clones, thus highlighting a correlation between PrP Sc production and infectivity. The 1C11 cell line used in our study exhibits the properties of a neuroectodermal stem cell. It expresses neuronal precursor cell markers and lacks neuronal functions (15) . Noteworthy, prion infection of mouse fetal brain-derived progenitors was recently achieved (31, 32) . That 1C11 precursor cells and neuronal stem cells sustain prion replication raises the possibility that prion accumulation may interfere with adult neurogenesis in TSE-affected animals or patients. Actually, recent data indicate that PrP C positively regulates embryonic and adult neurogenesis (33) . In view of the notion that prion pathogenesis involves some corruption of PrP C normal function in neuronal cells (34) , that PrP Sc could affect neuronal stem cell differentiation in TSEs deserves consideration.
Our data show that PrP Sc accumulation has no detectable effect on the phenotype of 1C11 undifferentiated cells. Prion replication does not alter the choice of fate of 1C11 cells, nor does it hinder the implementation of serotonergic or noradrenergic functions. On another hand, prion infection has drastic consequences on the overall bioamine metabolism of differentiated 1C11Fk progenies. Our study takes advantage of the homogeneous and synchronous onset of neurotransmitter synthesis, catabolism, storage and uptake in 1C11 5-HT or 1C11 NE cells (15) , and relies on pharmacological approaches to accurately quantify the overall phenotypic functions in infected cells. In both prion infected 1C11Fk 5-HT and 1C11Fk NE cells, we detect major impairments in bioamine synthesis, storage and uptake, and increases in serotonin or catecholamine catabolism. The prion-induced changes are comparable whether cells differentiate along the serotonergic or the noradrenergic pathway, adding to the significance of our observations. Besides, our quantitative analysis highlights a dose-dependent effect of prions on serotonergic or noradrenergic functions since the phenotypic alterations are all the more pronounced since the cells accumulate PrP Sc and infectivity (Fk6 vs. Fk7). It is of note that infection of 1C11 cells with Chandler prions promoted similar biochemical changes in differentiated cells (Supplementary Fig.2 ). While unprecedented in in vitro prion infection studies, our overall observations are in agreement with the perturbations of monoaminergic functions reported in various experimental models of prion diseases (see (35) for review and references therein). Our conclusions also fit in with clinical (e.g. depression, (36)) or functional (e.g. reduced SERT availability (37)) evidence for dysfunction of the 5-HT system in TSE-affected patients.
Here, one major finding is the detection of serotonin and catecholamine oxidation products in the supernatants of infected cells. Serotonin and catecholamines are highly prone to oxidation and are normally protected against oxidative attack by storage into synaptic vesicles. The formation of oxidized derivatives in the differentiated progenies of 1C11Fk infected cells likely involves alterations in 5-HT or CA storage. This idea is indeed substantiated by our observation that VMAT availability is reduced. Moreover, Wrona et al (28) reported that exposure of cytoplasmic 5-HT to hydroxyl radicals yields 5,6-DHT and 4,5 dihydroxytryptamine (4,5-DHT), itself converting into T-4,5-D. The 7,7'-D compound then arises from dimerization of T-4,5-D (28) . Similarly, defects in intracellular DA compartmentalization lead to the generation of 6-OHDA and quinones, and are thought to contribute to the pathogenesis of Parkinson's disease (38) . Because we detect these 5-HT or CA-derived oxidized compounds in the supernatants of 1C11Fk 5-HT or 1C11Fk NE infected cells, they are likely released through SERT-or NE transporter-mediated efflux (39) . The formation of oxidized derivatives of 5-HT and CA clearly mirrors elevated ROS levels in infected 1C11Fk
5-HT or 1C11Fk NE cells. That prion infection alters the cellular redox state in 1C11Fk cells is in keeping with various in vitro and in vivo observations (26, 27) , (40) . An enhanced ROS level could simply stem from a deviation of the signal transduction pathways normally coupled with PrP C , which involve the ROS-generating enzyme NADPH oxidase (41, 42) . Such a scenario would fit in with the current view that prion injury is primarily caused by distortions of PrP C normal function. What are the molecular mechanisms responsible for the alterations in bioamine metabolism in 1C11Fk progenies? The generation of 5-HT and CA oxidation products appears to greatly contribute to neurotransmitter dysfunction. Our data indeed demonstrate that 1C11Fk6 5-HTderived oxidized species have the potential to cancel TPH activity through modification of SH groups (Fig. 4) . A modification of critical cysteine residues by CA-derived quinones may also account for TH inactivation in 1C11Fk NE cells (43) . Because, T-4,5-D alters SERT function through reaction with sulfhydryl groups (44), we suspect oxidative attack on the SERT cysteines to be involved in transporter dysfunction as well. Actually, we observed that over 50% of the nonfunctional SERT molecules in 1C11Fk6
5-HT cells could revert to a functional state, upon treatment with a SH reducing agent (our unpublished observations). The same mechanism of SH oxidation may finally apply to the vesicular monoamine transporter, which contains multiple cysteine residues critical for tetrabenazine recognition (45) . Thus, generation of 5-HT and CA oxidation products capable to react with SH groups may deeply contribute to neurotransmitter dysfunction. The production of such bioaminederived oxidized species may also account for increased 5-HT or CA catabolism. 5,6-DHT concentrations below 1µM can induce a rapid depletion of 5-HT associated with an increase in the level of 5-HIAA (46) . The serotonin or catecholamine oxidation products act in a dosedependent manner (46) . At high concentrations, the neurotoxins 5,7-DHT and 6-OHDA selectively damage serotonergic or dopaminergic neurons, respectively (29) . Here, with 1C11Fk-derived progenies, these oxidized species exert toxicity at the level of neurotransmitter-associated functions only. The low concentration of these oxidation products in 1C11Fk 5-HT and 1C11Fk NE cells ( Fig. 2F and 5C ), may explain why the cells remain viable. Nonetheless, within the context of prion diseases latencies, chronic accumulation of bioamine-derived neurotoxins in infected neurons could progressively impair neuronal cell function and, in the long-term, lead to neuronal cell demise in TSEs. Collectively, our data draw a link between prion infection, cellular redox imbalance and dysfunctions in neurotransmitter metabolism. We may assume that the disruption of cell homeostasis involves prion-induced alterations in PrP C normal signaling activity (42, 47) . Because PrP Sc -induced biochemical alterations coincide with the acquisition of neurotransmitter-related functions, the 1C11 cell line may be a valuable model to investigate into the time-sequence of cellular insults, which contribute to the TSEassociated neurodegeneration. Another challenge will be the identification of therapeutic agents with the capacity to antagonize PrP Sc detrimental effects while preserving PrP C normal function.
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